Noticias y publicaciones

Fabry Disease

  • Lyso-GL-3: An important Fabry biomarker associated with adverse clinical outcomes

    Diagnostics , Publications abril 1, 2021

    Biomarkers in Rare Diseases play a dual and significant role in supporting improved clinical outcomes. In Fabry Disease (FD), the glycosphingolipid globotriaosylceramide (Gb3/GL-3) and its… Leer más